CSF2 and neoplasm: These vaccines can be produced from autologous or allogeneic tumor samples or cell lines, combined with adjuvants such as granulocyte and macrophage colony-stimulating factor (GM-CSF) and Bacillus Calmette-Guérin (BCG).